Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer

Study of Upifitamab Rilsodotin in Combination With Carboplatin in Participants With High-grade Serous Ovarian Cancer

Arizona Oncology Associates, PC – HOPE (USOR)

Tucson, Arizona, United States, 85701

Contact: Stacey Kimbell         

Principal Investigator: Joseph Buscema         

Lahey Clinic

Burlington, Massachusetts, United States, 01805

START Midwest

Grand Rapids, Michigan, United States, 49546

Contact: Katie Robinson         

Principal Investigator: Nehal Lakhani, MD         

Memorial Sloan Kettering

New York, New York, United States, 10021-0005

Contact: Caitlin Kaczynski         

Principal Investigator: Claire Friedman         

The Ohio State University Wexner Medical Center

Columbus, Ohio, United States, 43210

Contact: Delrina Crump         

Principal Investigator: John Hays         

Willamette Valley Cancer Institute and Research Center

Eugene, Oregon, United States, 97401

Contact: Jeanne Schaffer         

Principal Investigator: Charles K Anderson         

University of Pittsburgh Medical Center

Pittsburgh, Pennsylvania, United States, 15106

Contact: Gwendolyn Illar         

Principal Investigator: Timothy Burns         

Greenville Hospital System University Medical Center

Greenville, South Carolina, United States, 29605

SCRI Tenessee Oncology

Nashville, Tennessee, United States, 37011

Contact: Joshua Gash         

Principal Investigator: Erika Hamilton         

University of Utah Huntsman Cancer Institute

Salt Lake City, Utah, United States, 84112

Contact: Julia Lehman         

Principal Investigator: Theresa Werner, MD         

The Rector and Visitors of the University of Virginia

Charlottesville, Virginia, United States, 22903

Contact: Chrystal Axford         

Principal Investigator: Linda Duska         

Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care

Roanoke, Virginia, United States, 24014

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

February 24, 2023Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Comments